已收盘 08-14 16:00:00 美东时间
-0.650
-4.66%
GMR Solutions (NYSE:GMRS) affirms FY2026 sales outlook from $5.890 billion-$6.180 billion to $5.890 billion-$6.180 billion vs $6.018 billion estimate.
08-13 04:31
GMR Solutions (NYSE:GMRS) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.16) by 1050 percent. This is a 781.48 percent decrease over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $1.490 billion w...
08-13 04:31
全美最大的急救医疗服务提供商GMR Solutions宣布,任命Amar Desai博士和Ellen Zane为董事会成员,自2026年7月1日起生效。 ...
07-08 22:17
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
JP Morgan analyst Benjamin Rossi initiates coverage on GMR Solutions (NYSE:GMRS) with a Overweight rating and announces Price Target of $15.
06-08 21:06
GMR Solutions (NYSE:GMRS) released first-quarter financial results and hosted a...
06-02 22:52
GMR Solutions (NYSE:GMRS) sees FY2026 sales of $5.890 billion-$6.180 billion.
06-02 04:42
GMR Solutions (NYSE:GMRS) reported quarterly earnings of $0.28 per share. This is a 1033.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported $1.458 billion in sales
06-02 04:33